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SUMMARY
Women treated for breast cancer have shown cognitive deficits with reduced capacity to focus and concentrate or to
direct attention. This study examined the relationship between cognitive function prior to any treatment for breast
cancer and individual factors including age, education, menopausal status, chronic health problems, and distress.
Women newly diagnosed with breast cancer (N=184), ages 27–86 years, were assessed with standardized attention
tests, self-reports of effectiveness in cognitive functioning, and measures of distress at about 18 days before surgery.
Measured performance on the cognitive tests was not significantly correlated to self-reports of effectiveness in
cognitive functioning. Age, education, presence of a chronic health problem, and menopausal status, but not
distress, were associated with performance on the cognitive tests. Only age and education, however, were significant
(p50.001) predictors of overall performance on the cognitive tests, when controlling covariates. In contrast,
symptom and mood distress significantly (p50.001) predicted perceptions of effectiveness in cognitive functioning.
Thus, different factors were associated with measured performance versus self-reports of cognitive functioning.
Individual factors that predispose to lowered effectiveness in cognitive functioning prior to treatment in women
newly diagnosed with breast cancer are discussed. Copyright # 2004 John Wiley & Sons, Ltd.
INTRODUCTION
A growing number of studies have documented the
presence of cognitive deficits in women treated for
breast cancer. A common finding across studies is
the presence of problems of attention and con-
centration of varying severity during and following
breast cancer treatment (Ahles and Saykin, 2001;
Cimprich and Ronis, 2001). The capacity to focus
and concentrate, or to direct attention, is essential
for effective cognitive functioning. A strong
Capacity to Direct Attention (CDA) is needed to
acquire important information, to make decisions,
and to carry out self-care activities. Increasing
understanding of problems of attention is of key
importance in individuals treated for cancer, since
this cognitive capacity supports higher-level cog-
nitive functions (Posner and Dehaene, 1994; Smith
and Jonides, 1999). Little research has been done
to determine what factors might predispose
women newly diagnosed with breast cancer to
impairments of attention. Thus, the purpose of
this study was to examine possible factors that
might be associated with the capacity to direct
attention prior to any treatment in women newly
diagnosed with breast cancer.
Directed attention refers to the cognitive ability
to actively block or inhibit a competing stimulus in
purposeful or goal-directed activity (James, 1983;
Posner and Dehaene, 1994; Posner, 1995). In
particular, the capacity to direct attention permits
purposeful mental activity through inhibition of
distractions or competing information in the
environment (internal or external) (James, 1983;
Kaplan and Kaplan, 1982; Posner and Dehaene,
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1994; Posner, 1995). This form of selective atten-
tion is also known as voluntary or controlled
attention (James, 1983; Kaplan and Kaplan, 1982;
Posner and Dehaene, 1994; Posner, 1995). Direc-
ted attention provides neural inhibitory control for
key aspects of cognitive function, including
perception and working memory (Posner and
Dehaene, 1994; Posner, 1995) and supports high-
er-level executive functions such as acquiring
information, planning and carrying out effortful
tasks, and regulating behavior to meet desired
goals (Smith and Jonides, 1999; Lezak, 1995).
Thus, the CDA is of fundamental concern when
considering possible cognitive deficits in indivi-
duals with cancer, since even a small loss in
attentional capacity can interfere with mental
clarity and higher-level cognitive activities.
The presence of cognitive deficits, including
subtle and more severe problems of attention,
has been documented during and following
chemotherapy for breast cancer (for comprehen-
sive reviews see Ahles and Saykin, 2001; Phillips
and Bernhard, 2003). The reported incidence of
cognitive deficits following chemotherapy for
breast cancer ranges from 17% to 35% (Ahles
and Saykin, 2001). Fatigue-related losses in CDA
also have been documented following breast
cancer surgery (Cimprich, 1992, 1993, 1999). In
most instances the research has been done follow-
ing the initiation of cancer treatment. Although
certain individual factors, such as age, education,
menopausal status, and psychological distress can
affect CDA, little research has been done to
determine to what extent such factors influence
attention in women diagnosed with breast cancer
prior to any treatment.
Aging has been associated with a loss of CDA in
healthy, cognitively intact, older men and women
in a large number of studies (e.g. Braver et al.,
2001; Allen et al., 2001; Ylikoski et al., 1998; Zacks
and Hasher, 1994), indicating a loss of efficiency in
directing attention in a demanding or distracting
environment, as would be expected when dealing
with a diagnosis of breast cancer. In this regard,
older women, 55–79 years of age, newly diagnosed
with breast cancer showed significantly lower
CDA prior to any treatment than women similar
in age without breast cancer (Cimprich and Ronis,
2001).
A key aspect of physiological aging in women is
the reduction in reproductive hormones with
normal menopause. Reductions in estrogen and
progesterone in post-menopausal women have
been associated with cognitive changes, involving
a decline in attention, learning and memory;
however, it has not been determined how meno-
pausal status might affect cognitive function in
women newly diagnosed with breast cancer
(Bender et al., 2001).
Education has been shown to affect perfor-
mance scores over a wide number of cognitive
measures in healthy individuals (Lezak, 1995;
Leckliter and Matarazzo, 1989; Capitani et al.,
1996). In general, higher levels of education have
been associated with better performance on
measures of attention, particularly on verbal
measures and more complex or effortful tasks
requiring directed attention (Lezak, 1995).
Mood distress, including depressive symptoms
and anxiety, has been more generally associated
with self-reports (perceptions) of poorer cognitive
functioning in individuals with cancer. Self-reports
of attention and memory problems in 91 disease-
free, adult survivors of lymphoma were related to
higher affective distress scores including anxiety
and depression, but not to actual performance on
objective neuropsychological measures (Cull et al.,
1996). Similarly, following standard or high dose
chemotherapy for breast cancer, women’s subjec-
tive reports of problems with attention and
memory were related to psychological distress
but not to actual performance on the objective
test measures (van Dam et al., 1998). Finally, a
study of 74 women newly diagnosed with breast
cancer also showed that higher mood distress
scores in the pre-treatment period were signifi-
cantly correlated with perceptions of lowered
effectiveness in cognitive functioning (Cimprich,
1999). Taken together, these findings suggest a
more global relationship between affective distress
and perceptions of lowered effectiveness in cogni-
tive functioning (and vice versa) in individuals with
cancer that appears to be unrelated to cognitive
performance on neuropsychological testing.
In summary, previous studies in healthy popula-
tions and individuals with cancer suggest a number
of factors that might interfere with CDA. How-
ever, there has been no previous research to
determine whether or to what extent such factors
might affect attention and cognitive functioning
prior to any treatment in women newly diagnosed
with cancer. Thus, the purposes of this study were
to determine: (a) the relationship of CDA with
pertinent demographic and medical characteris-
tics, that is, age, menopausal status, education
and presence of health problems, prior to any
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treatment in women newly diagnosed with breast
cancer; (b) the relationship of CDA with pre-
treatment symptom distress and mood state;
and (c) the combined value of demographic and
medical characteristics and distress factors in




The study participants were 184 female volun-
teers drawn from the population of patients
treated for breast cancer at a university medical
center with a comprehensive cancer treatment
program. Only patients with early stage (Stages
0, I, or II) breast cancer were eligible for the study.
Individuals were excluded for pre-existing condi-
tions that could influence CDA or performance of
measures, such as documented cognitive, mental,
or affective disorders, prescribed medication
known to enhance or impair attention, and
insufficient command of the English language.
A description of demographic and medical
characteristics is shown in Table 1. The women
ranged in age from 27 to 86 years and were
relatively well educated, with about 76% having at
least some college education. The majority of
participants were married, and 90% were white.
Half of the respondents (50%) reported having
some other chronic health problem such as
hypertension, diabetes or heart disease. The
majority of the women were post-menopausal
and were diagnosed with Stage I breast cancer.
None of the women in the study reported being on
hormone replacement therapy at the time of
testing.
MEASURES
The measures of CDA, or the ability to inhibit a
competing stimulus while focusing on a task, were
Digit Span and the Trail Making test. Both tests
are theoretically congruent requiring inhibition of
a competing stimulus to perform the task accu-
rately. In addition, a measure of short-term
memory, Three Shapes and Three Words, was
included since there is a close functional connec-
tion between attentional control and short-term
memory, with working memory especially vulner-
able to loss of inhibitory control. Perceptions of
effectiveness in activities requiring directed atten-
tion was measured with a self-rating scale, the
Attentional Function Index.
Digit Span: This standardized test of attention
consists of two separate measures, Digit Span
Forward (DSF) and Backward (DSB) (Lezak,
1995). DSF measures the bits of information that a
person can attend to at one time in a task requiring
repetition of a random series of digits presented at
a rate of one digit per second. DSB, the more
rigorous test, requires sustained directed attention
to mentally track and reverse a random series of
digits. The scores were the number of digits
repeated correctly in forward (DSF) and backward
(DSB) sequences before two failed trials.
Trail Making Test (TMT) (Reitan, 1958): The
TMT is a standard test of attention (Lezak, 1995)
requiring effective inhibition of competing responses








High school or less 32 (21)
College (full/some) 107 (54)
Graduate degree 40 (22)


















Not reported 7 (4)
aSingle=Widowed, divorced, separated, never married.
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to correctly complete the task in a timely manner.
The TMT consists of two parts. In part A, the
participant is required to connect a series of
randomly placed circles numbered 1–25 in correct
order as quickly as possible. Part B, the higher
demand condition, requires the participant to
connect a series of 25 circles numbered 1–13
randomly interspersed with letters A–L, alternat-
ing between numbers and letters (1 to A, A to 2,
2 to B, etc.). The investigator points out errors as
they occur so that the participant can make the
corrections. For both Part A and Part B, the score
is the number of seconds required to complete the
test, including the time for corrections.
Three Shapes (TS) and Three Words (TW)
(Mesulam, 1985) are measures of the effectiveness
of short-term memory and retention of informa-
tion including acquisition of new information,
which require attentional control. The participant
is asked to copy six test stimuli, i.e. three shapes
and three words with low imagery value. One
minute after the stimuli are removed the individual
is asked to reproduce them from memory. The
scores are the number of correct responses in
reproducing the words and the shapes in immedi-
ate recall.
Attentional Functional Index (AFI) (Cimprich,
1992) was used to measure subjective or perceived
effectiveness in cognitive activities requiring
directed attention such as planning daily activi-
ties, getting started on tasks, making decisions,
keeping a train of thought, remembering to do
important things, and attending to details. The
instrument consists of 16 linear analogue scales
(each 100mms.) labeled at either end with polar
opposite phrases (e.g. ‘not at all’ and ‘extremely
well’). The respondents were asked to place a
mark through the horizontal line at whatever point
best described how well they were functioning at
the time. Validity and reliability have been
established in healthy and ill populations (Cim-
prich, 1992, 1999). In this sample, the internal
consistency coefficient was 0.91, indicating good
reliability.
Symptom Distress Scale (SDS) (McCorkle and
Young, 1978) was used to measure the degree of
distress experienced in relation to 10 common
symptoms such as fatigue, insomnia, and loss of
appetite. Responses were made on a five-point
scale ranging from 1 (no problem) to 5 (the worst
possible problem). The SDS has been widely used
in studies involving patients with cancer and has
established validity and reliability (McCorkle and
Quint-Benoliel, 1983). In this research, the internal
consistency coefficient was 0.80, indicating satis-
factory reliability.
Profile of Mood States-Short Form (POMS-SF)
(McNair et al., 1992) was used to assess mood
state. The short form consists of 30 adjectives that
represent six mood states, namely, anxiety, anger,
depression, vigor, confusion, and fatigue. Respon-
dents rated themselves on a five-point scale
ranging from 0 (not at all) to 4 (extremely) in
response to feelings during the past week. Because
of scoring procedures with vigor negatively
weighted, the summed score on the measure can
range from a low of –20 (no distress) to high of 100
(worst distress). Validity and reliability of the
POMS and subscales have been established in
varying populations. In this research, internal
consistency for the subscales ranged from 0.78
to 0.92 and the coefficient for the total POMS-SF
was 0.87.
PROCEDURE
The university’s Health Sciences Institutional
Review Board approved the study. Following
written consent, testing was conducted during a
scheduled pre-treatment clinic visit in a quiet,
private room in the ambulatory care area. A
trained research assistant administered the tests in
random sequence using standard formats and
instructions. Testing occurred at about 23 days
following diagnosis by biopsy and about 18 days
before surgery.
DATA ANALYSIS
Descriptive statistics were used to characterize the
sample of women newly diagnosed with breast
cancer on demographic and medical variables.
Pearson correlation coefficients were used to
determine relationships between cognitive vari-
ables and selected demographic and distress
variables. Multiple regression analyses were per-
formed to determine possible predictors of cogni-
tive functioning prior to breast cancer treatment.
For certain analyses, a composite score of atten-
tional performance, the Total Attentional Score
(TAS), was computed by transforming raw scores
on the objective tests to Z scores based on the
mean and standard deviation of the sample,
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reversing scores on certain tests so that higher
scores represented better performance, and sum-
ming the standardized scores (DSF+DSB+
TMA+TMB). For all other analyses, raw scores
were used.
RESULTS
Performance on cognitive measures
Scores on the objective tests of attention
and short-term memory are reported in Table 2.
When compared with available age-normed data
(Lezak, 1995; Spreen and Strauss, 1998), the mean
scores of the attention tests generally fell within
the normal range for healthy adults. On the
subjective measure of perceived effectiveness in
cognitive functioning, the AFI, scores ranged from
a low of 17 to a high of 97 with a mean of
65.7 (SEM=1.38). A further examination of the
frequencies indicated that only 25% scored above
75 indicating effective functioning, with 50%
reporting moderate effectiveness (score of 50–75)
and 25% reporting lower effectiveness (score
below 50).
Relationship of cognitive measures: age, menopau-
sal status, education, and comorbidity
The correlations between scores on cognitive
measures and selected study variables are shown
in Table 3. There were no significant relationships
between scores on the self-report measure, the
AFI, and performance on the objective tests of
attention and short-term memory.
Age was significantly correlated with the
objective attention and short-term memory mea-
sures with the exception of DSF. The Pearson
correlations were small to moderate ranging
from 0.16 to 0.47 with older age related to poorer
Table 2. Test scores of total sample
M SEM Min–Max
Attention tests:
Digit Span Forward (DSF) 6.62 0.10 4–9
Digit Span Backward (DSB) 4.75 0.10 3–8
Trail Making Test A (TMA) (s) 34.18 1.24 13–119
Trail Making Test B (TMB) (s) 71.33 2.70 21–285
Short-term memory:
Three Shapes (1min) 2.80 0.04 0–3
Three Words (1min) 2.61 0.05 0–3
Rating scales:
Attentional Functional Index (AFI) 65.69 1.38 17–97
Symptom Distress Scale (SDS) 20.51 0.43 11–36
Profile of Mood State (POMS-SF) 19.40 1.54 13–82
Table 3. Correlation of cognitive measures with selected demographic and distress variables
AFI Age Education POMS-SF SDS
Digit span forward 0.04 0.12 0.22 0.12 0.10
Digit span backward 0.11 0.18 0.27 0.18 0.11
Trail making A 0.04 0.47 0.13 0.11 0.03
Trail making B 0.02 0.44 0.22 0.21 0.17
Total attention score 0.12 0.43 0.29 0.23 0.15
Three shapes (1min) 0.07 0.16 0.18 0.12 0.06
Three words (1min) 0.01 0.16 0.02 0.04 0.13
Attentional function index – 0.23 0.01 0.62 0.58
Note: AFI=Attentional Function Index; POMS-SF = Profile of Mood States-Short Form; SDS=Symptom Distress Scale.
50.05; 50.01; 5 0.001.
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performance. Age also was significantly related
to scores on the subjective measure, the AFI;
however, in contrast to performance on objec-
tive measures, younger age was associated with
perceptions of poorer effectiveness in cognitive
functioning.
Menopause status groups (pre-, peri-, and post-
menopausal) differed significantly on three tests
(not tabled), TMA and TMB and the Three Words
Recall, with the post-menopausal (older) group
having poorer performance, p50.05, on these tests
as compared to the pre-menopausal (younger)
group (TMA: M=27 versus 37; TMB: M=53
versus 81; Three Words Recall: M=2.8 versus
2.5, pre- and post-menopausal groups, respec-
tively). The small group of peri-menopausal
women (n=13) did not differ significantly from
either the pre- or post-menopausal groups on any
of the objective measures.
On the subjective measure of attentional func-
tioning, the AFI, there was a significant difference
between the pre- and post-menopausal groups,
with the pre-menopausal (younger) group report-
ing significantly lower effectiveness in cognitive
functioning (M=60), F (2171)=3.19, p=0.04,
compared to the post-menopausal (older) group
(M=68). Again, the peri-menopausal group
did not differ (M=65) from either the pre-
or post-menopausal groups on this subjective
measure.
Years of education were significantly corre-
lated with the objective measures with the excep-
tions of Trail Making A and the Three Words
memory task. The size of the correlations in
this relatively well-educated sample was small,
ranging from 0.18 to 0.29, and generally indica-
ted that more years of education were associa-
ted with better performance on these cognitive
measures. There was no significant relation-
ship between years of education and scores on
the AFI, the subjective measure of cognitive
functioning.
Presence of other chronic health problems was
associated with significant differences in perfor-
mance on the cognitive measures, with the group
reporting presence of chronic health problems
having significantly poorer scores on TMA,
t (177)=4.57, p50.001, TMB, t (177)=4.37,
p50.001, and TW (1min), t (177)=2.93, p=0.004.
There were no significant differences in mean
scores on the subjective measure of cognitive
functioning, the AFI, based on presence or
absence of a chronic health problem.
Relationship of cognitive measures and symptom
distress
The scores on the symptom distress scale ranged
from a low of 11 to a high of 36 with a mean of
20.51 (SEM=0.43) indicating a low to moderate
level of symptom distress prior to any treatment
(see Table 2). The most frequently reported
symptoms that produced some level of distress
were mood state disturbance (91%), insomnia
(76%), and fatigue (75%). There were no sig-
nificant relationships between symptom distress
scores and performance on the objective measures
of attention and short-term memory with the
exception of one test (TMB) (see Table 3).
However, there was a significant, moderately
strong, inverse relationship between symptom
distress and scores on the AFI. As symptom
distress increased, perceived effectiveness in cog-
nitive functioning decreased, and vice versa.
The scores on the POMS-SF, a measure of
affective distress, ranged from a low of –13 to a
high of 82 (see Table 2). Given the possible range
of scores, the mean of 19.40 (SEM=1.54) indi-
cated an overall low level of mood distress prior to
treatment. At the same time, 25% of the partici-
pants scored over 30 on the measure, indicating
presence of moderate to high distress. There were
small but significant relationships (p50.05) be-
tween POMS-SF and scores on two cognitive
measures, DSB and TMB (see Table 3). Of
interest, the direction of the correlations indicated
that better performance on these two measures
was associated with higher affective distress. A
further examination of relationships of cognitive
measures with POMS-SF subscale scores indicated
that, in particular, anxiety scores were inversely
correlated with performance of the cognitive
measures suggesting that increased anxiety tended
to enhance performance on these tests.
There was a significant and strong relationship
between POMS-SF scores and the subjective
measure of effectiveness in cognitive function, the
AFI. Higher levels of perceived effectiveness in
cognitive functioning were associated with lower
levels of affective distress.
Pre-treatment predictors of cognitive functioning
To determine possible predictors of perfor-
mance on objective measures of directed attention
in the pre-treatment period, a multiple regression
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analysis was performed using the composite Total
Attention Score (TAS) as the dependent variable.
Age, years of education, menopausal status (post-
versus pre- or peri-menopausal), presence or
absence of chronic health problems, and overall
scores for Symptom Distress Scale (SDS) and
POMS-SF were entered as independent variables.
Together these variables accounted for 29% of the
variance in the TAS prior to breast cancer
treatment, Multiple R=0.54, F (6, 162)=10.48,
p50.001 (see Table 4). Only two variables, age
and years of education, were found to be
significant predictors of objective attentional
performance. Conversely, menopausal status, pre-
sence of a chronic health problem, and levels of
symptom (SDS) and affective (POMS-SF) distress
were not significant predictors of attention in the
pre-treatment period.
To determine possible predictors of subjective or
perceived effectiveness in cognitive functioning in
women prior to treatment for breast cancer, a
multiple regression analysis was performed using
the overall AFI score as the dependent variable.
Again, age, years of education, menopausal status,
other chronic health problems, and overall scores
for SDS and POMS-SF were entered as indepen-
dent variables as described above. Together these
variables explained 43% of the variance in the
AFI scores, Multiple R=0.65, F (6, 168)=20.14,
p50.001 (see Table 5). Two variables, SDS and
POMS-SF scores, were found to be significant
predictors of perceived effectiveness in cognitive
functioning, whereas age, education, menopausal
status and presence of chronic health problems
were not significant predictors.
DISCUSSION
This study examined individual factors associated
with the cognitive capacity to direct attention prior
to any treatment in women newly diagnosed with
breast cancer. The findings indicated that scores
on the objective measures were not significantly
related to subjective perceptions of cognitive
functioning in activities requiring directed atten-
tion. Furthermore, when controlling for possible
covariates, age and education were significant
predictors of overall performance on the objective
measures of attention prior to any treatment, while
levels of symptom and affective distress signifi-
cantly predicted perceptions of the effectiveness in
cognitive functioning.
As might be expected, older age was associated
with poorer performance on the measures. In
contrast, on the self-report measure, younger
women reported less effectiveness in cognitive
Table 4. Multiple regression analysis of Total Attention Score (TAS)a to identify pre-treatment predictors
Variables B SE B Beta Significance
Age 0.11 0.03 0.43 50.001
Education 0.33 0.08 0.28 50.001
Health problems 0.51 0.41 0.09 0.21
Profile of mood states 0.02 0.01 0.18 0.07
Symptom distress 0.01 0.05 0.03 0.78
Menopausal status 0.80 0.59 0.14 0.18
aTAS=Total Attentional Score (sum of standardized scores DSF+DSB+TMA+TMB).
Table 5. Multiple regression analysis of Attentional function Index (AFI) to identify pre-treatment predictors
Variables B SE B Beta Significance
Age 0.006 0.14 0.004 0.96
Education 0.38 0.45 0.05 0.41
Health problems 0.14 2.25 0.004 0.95
Menopausal status 1.79 1.74 0.09 0.30
Symptom distress 1.02 0.26 0.32 50.001
Profile of mood states 0.34 0.07 0.38 50.001
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functioning than the older women, suggesting that
younger women may have perceived even small
fatigue-related losses in attention that interfered
with usual levels of functioning, but that were not
detectable on testing. Older women, however, may
have adapted their expectations of effective func-
tioning in keeping with life demands and a more
gradual decline in attentional performance over
time. Despite reports of more effective functioning,
however, older women demonstrated decreased
ability to direct attention prior to any treatment,
indicating a greater susceptibility to possible
treatment-related losses in cognitive functioning
over time.
Higher educational level was related to better
performance on most of the objective measures,
although the relationships were relatively small.
The sample tended to be well educated, however,
and this may have accounted for the small size of
the observed relationships. Nevertheless, educa-
tion did remain a significant predictor of atten-
tional performance even after taking into account
age and other possible covariates.
Menopausal status was not a significant pre-
dictor of overall performance on the attention
measures when taking into account age, suggesting
that age may explain the observed relationship of
menopausal status with cognitive functioning.
Also, although presence of a chronic health
problem, such as diabetes, hypertension, and heart
disease, was associated with poorer performance
on objective measures, having a co-morbid condi-
tion was not a significant predictor of attentional
performance when controlling for other covari-
ates. Thus, the study provides clear evidence of the
effect of age that is not explained by menopausal
status or chronic illness, but no evidence of the
effects of menopausal status or chronic illness that
is not explained by age.
Distress levels generally were not associated
with performance on the objective tests. The mean
scores on the POMS-SF indicated generally low to
moderate levels of distress prior to the start of
treatment (about three weeks following diagnosis).
It is possible that such low to moderate levels of
distress were not sufficient to have any effect on
performance of the selected tests, and that
moderately heightened anxiety could enhance
attention.
In relation to subjective perceptions of atten-
tional functioning, a different pattern of relation-
ships and predictors emerged. Perceptions of
cognitive problems were related to higher psycho-
logical distress but not to actual performance on
the objective tests of attention and short-term
memory. After controlling for possible covariates,
symptom distress and affective distress were
significant predictors of how well the women
perceived they were functioning in everyday
activities that required directed attention such as
carrying out effortful tasks, making decisions, and
being able to take in information. Similar results
have been reported in samples of lymphoma
patients in remission (Cull et al., 1996) and of
breast cancer patients following standard or high
dose chemotherapy (van Dam et al., 1998). In
those studies, complaints of problems in attention
and memory were related to greater affective
distress but not to performance on objective
measures. Cull et al. (1996) proposed that com-
plaints of problems in attention and memory
reflected affective disorder and mental fatigue.
An explanation of affective disorder seems unlikely
in this sample since scores on the POMS-SF
generally reflected low to moderate levels of
distress. One other explanation may be that even
small fatigue-related losses in attention may
contribute to overall experience of distress because
keeping up with the demands of daily life becomes
more difficult. Because the neuropsychological
tests used in this study do not reflect the complex-
ities of daily tasks, they may be less sensitive to
subtle losses in cognitive functioning that might be
perceived by an individual. In this regard, women
in this study frequently described distressing lapses
in attention and memory that occurred since the
diagnosis of breast cancer. Such losses in cognitive
function following prolonged or intense mental
demands have been associated with mental or
‘attentional’ fatigue (Kaplan, 1995) and appear to
be amenable to interventions to enhance attention
(Cimprich, 1993; Cimprich and Ronis, 2003).
Overall the findings provide new evidence of
factors that might influence attentional function-
ing even prior to breast cancer treatment. Of
interest, the findings suggest that self-reports are
not accurate indicators of cognitive performance.
At the same time, measured performance on tests
such as those used in this study may not accurately
reflect the cognitive problems that many women
experience following diagnosis of breast cancer.
Importantly, the findings indicate that different
factors were associated with measured perfor-
mance versus self-reports of cognitive functioning.
Longitudinal investigations are especially needed
to better understand how individual factors such
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as age and distress may predispose individuals
to cognitive impairments, particularly losses in
attention, during and following breast cancer
treatment.
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